Psychiatrie pro praxi – 3/2019

www.psychiatriepropraxi.cz e26 PŘEHLEDOVÉ ČLÁNKY Depresivní příznaky u jednotlivých neurologických poruch PSYCHIATRIE PRO PRAXI 22. Paykel ES, Brugha T, Fryers T. Size and burden of depressive disorders in Europe. Eu- ropean neuropsychopharmacology 2005; 411–423. 23. Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G, Girardi P. Suicide risk in multiple sclerosis: a systematic review of current literature. Journal of psychosomatic rese- arch 2012; 73(6): 411–417. 24. Radu SV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psy- chiatric Clinics 2012; 51–71. 25. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease. Neurology 2007; 69(4): 342–347. 26. Reijnders MA, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of preva- lence studies of depression in Parkinson’s disease. Mov Disord Epub 2007; 23(2): 183–189. 27. Robinson RG, Jorge RE. Post-stroke depression: a review. American Journal of Psychia- try 2016; 173(3): 221–231. 28. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. Journal of Neuro- logy, Neurosurgery & Psychiatry 2005; 76(4): 469–475. 29. Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP. Prevalence, clinical mani- festations, etiology, and treatment of depression in Parkinson's disease. The Journal of neu- ropsychiatry and clinical neurosciences 2001; 13(2): 187–196. 30. Torta R, Ieraci V. Migraine and depression comorbidity: antidepressant options. Neurologi- cal Sciences 2012; 33(1): 117–118. 31. Turner AP, Williams RM, Bowen JD, Kivlahan DR, Haselkorn JK. Suicidal ideation in mul- tiple sclerosis. Archives of physical medicine and rehabilitation 2006; 87(8): 1073–1078. 32. World Health Organization. MKN–10: Mezinárodní klasifikace nemocí a přidružených zdravotních problémů: desátá revize. Aktualizovaná druhá verze k 1. 4 2014.